Sign in

CIK 0001858848

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813789973
Phone
+1 415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-11-17 Casdin Eli Director Purchase +2,492,042 $2.60 $6.5M 6,078,860
2022-11-17 Casdin Eli Director Purchase · Warrant +1,354,111 $2.60 $3.5M 1,354,111
2022-09-08 Parschauer Karah Herdman Director Grant or award · Stock Option (Right to buy) +20,000 20,000
2022-06-10 Walsh Jeffrey T. Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-06-10 Stehman-Breen Catherine Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-06-10 Srivastava Deepak Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-06-10 Lee June Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-06-10 GOEDDEL DAVID V Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-06-10 CHEN JIN-LONG Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-06-10 Casdin Eli Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-06-10 Williams R Sanders Director Grant or award · Stock Option (Right to buy) +39,727 39,727
2022-04-26 Hoey Timothy Chief Scientific Officer Sale −1,353 $10.13 $14K 198,646
2022-02-15 Ali Faraz Chief Executive Officer Grant or award · Stock Option (Right to buy) +401,390 401,390
2022-02-15 PATTERSON LEONE D Chief Fin. and Bus. Officer Grant or award · Stock Option (Right to buy) +66,000 66,000
2022-02-15 Tingley Whittemore Chief Medical Officer Grant or award · Stock Option (Right to buy) +141,000 141,000
2022-02-15 Hoey Timothy Chief Scientific Officer Grant or award · Stock Option (Right to buy) +168,000 168,000
2021-12-22 Parschauer Karah Herdman Director Grant or award · Stock Option (Right to Buy) +19,495 19,495
2021-11-19 Lee June Director Grant or award · Stock Option (Right to Buy) +18,937 18,937
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion +4,389,282 4,414,720
2021-08-03 COLUMN GROUP III GP, LP 10% owner Conversion +4,956,842 4,985,570

Page 10 of 12 · 228 trades